@JayKell04956433 @alexandrite113 ‘Long-COVID’: a cross-sectional study of persisting symptoms, biomarker and imaging abnormalities following hospitalisation for COVID-19 https://t.co/d9avoyfALf a study from 2020 @pplates
@SIMONCU46424244 @jathorpmfm Ok so how did they know to publish papers studying long covid before the vaccine came out https://t.co/1lSqwiTvjG
@kevinnbass With persistently elevated d-dimer and C reactive protein, along with abnormal chest radiographs in many, it’s seems that a persistent viral reservoir can be at play. https://t.co/tntH5wsPye
@OktayTR57 @tagesschau Aber du kannst gerne auch die Quellen nutzen alle von 2020, wie erklärst du dir das? https://t.co/4rJI435yzF https://t.co/FfRm34Vx7m https://t.co/j6JlnscU50 https://t.co/zlTpPImciD https://t.co/xd20V8IR6v
@kutschera_u Und was ist mit denen, die im Jahr 2020 daran erkrankt sind, sind das Geimpfte, die eine Zeitreise durchgemacht haben? Das können Sie doch bestimmt erklären, nicht wahr? https://t.co/T6ddUIkdRt https://t.co/oNkeoZPxKX https://t.co/zsDduNub8w
@jordanschumway @COVID_tits @TheBabelFish1 @thechrislarsen Oh nice, this one has MRI evidence and biomarkers. Crushing this plague rat's whole argument with a single link. https://t.co/GXDDOtVMrM
@michealleclerc @BreeNewsome It’s a little bit of a silver lining, that COV ran rampant for 15months before meaningful vaccine uptake. We can show that everything Antivaxxers blame on vaccine was worse before vaccine. PreVax research https://t.co/vx1JqPidi
RT @exosome: #longcovid associated with elevated markers of #inflammation such as D-Dimer and CRP...this may be one of the reasons why #qua…
RT @exosome: #longcovid associated with elevated markers of #inflammation such as D-Dimer and CRP...this may be one of the reasons why #qua…
RT @exosome: #longcovid associated with elevated markers of #inflammation such as D-Dimer and CRP...this may be one of the reasons why #qua…
#longcovid associated with elevated markers of #inflammation such as D-Dimer and CRP...this may be one of the reasons why #quadramune by $TSOI seems to help some of these patients...since it decreases inflammation https://t.co/nj2x4LurKP
An even wearier writer that if you're not actually an expert in the field, maybe you shouldn't be opining from your lofty perch about things outside of your area of expertise. https://t.co/B0YBNqiaLy
#Longcovid: a cross-sectional study of persisting symptoms, biomarker and imaging abnormalities following hospitalisation for #COVID-19 https://t.co/lmkL5Ikuzd
@JaneBar90697098 @sammy4723 Hi Jane roped in a friend to round up some info Autoantibodies leading bio markers in long Covid https://t.co/22sUsB8OOE Inflammatory bio markers - popular article https://t.co/9tj04fMGAb Neuropsychiatric bio markers https:
RT @BritishHIVAssoc: Impressive overview of the challenges how to set up a post COVID service based on experience of > 1000 patients at @…
RT @drjanenicholls: What happened to the people we sent home? ( hospitalised with #COVID) Great work setting up this clinic Mobilise W…
What happened to the people we sent home? ( hospitalised with #COVID) Great work setting up this clinic Mobilise Work flexibly @lung_live4eva #BHIVA2022 #LongCovid
RT @BritishHIVAssoc: Impressive overview of the challenges how to set up a post COVID service based on experience of > 1000 patients at @…
Impressive overview of the challenges how to set up a post COVID service based on experience of > 1000 patients at @RoyalFreeNHS looking at psychological impacts breathing pattern disorders functional recovery @lung_live4eva #BHIVA2022 Paper htt
RT @janlotvall: We need to systematically follow up patients that have had #COVID19 for '#LongCovid': a cross-sectional study of persisting…
RT @janlotvall: We need to systematically follow up patients that have had #COVID19 for '#LongCovid': a cross-sectional study of persisting…
RT @janlotvall: We need to systematically follow up patients that have had #COVID19 for '#LongCovid': a cross-sectional study of persisting…
RT @janlotvall: We need to systematically follow up patients that have had #COVID19 for '#LongCovid': a cross-sectional study of persisting…
RT @janlotvall: We need to systematically follow up patients that have had #COVID19 for '#LongCovid': a cross-sectional study of persisting…
RT @janlotvall: We need to systematically follow up patients that have had #COVID19 for '#LongCovid': a cross-sectional study of persisting…
RT @janlotvall: We need to systematically follow up patients that have had #COVID19 for '#LongCovid': a cross-sectional study of persisting…
We need to systematically follow up patients that have had #COVID19 for '#LongCovid': a cross-sectional study of persisting symptoms, biomarker and imaging abnormalities following hospita… https://t.co/ICU0qygUoQ
@loscharlos Thanks Charlos…I’m guessing you’re referring to D- Dimer (or is it something else?). A quick re-scan of a few articles: Sensitivity seems poor. And is is known to be non-specific..why in acute VTE it is useful to rule _out_ clot but not rule in
@emporer_naked @MarkELindsay Doesn’t appear subjective - there’s a lot of long COVID research conducted via medical data incl. imaging, lipids analysis & blood sampling. Survey data can be useful but it’s poor form not to acknowledge its limitations. h
@DrRodenb1 @Gewuerztee Sie nennen sich "Dr." und schwadronieren über Phantome? Wie wäre es mal mit etwas primärwissenschaftlicher Lektüre? - https://t.co/ZL5A41ISof - https://t.co/29qTcsJklh - https://t.co/2BW4Z6J2xq - https://t.co/TP0mXSOSe8 - https://t.
RT @gloquenzi: C’è sempre una grande, ingombrante e sottovalutata differenza tra il Covid e l’influenza… Long-COVID’: a cross-sectional stu…
Ma ti rendi conto che bisogna ancora spiegarglielo?🙃
RT @gloquenzi: C’è sempre una grande, ingombrante e sottovalutata differenza tra il Covid e l’influenza… Long-COVID’: a cross-sectional stu…
I vaccini non proteggono dal covid ma dal long covid.
RT @gloquenzi: C’è sempre una grande, ingombrante e sottovalutata differenza tra il Covid e l’influenza… Long-COVID’: a cross-sectional stu…
RT @gloquenzi: C’è sempre una grande, ingombrante e sottovalutata differenza tra il Covid e l’influenza… Long-COVID’: a cross-sectional stu…
RT @gloquenzi: C’è sempre una grande, ingombrante e sottovalutata differenza tra il Covid e l’influenza… Long-COVID’: a cross-sectional stu…
RT @gloquenzi: C’è sempre una grande, ingombrante e sottovalutata differenza tra il Covid e l’influenza… Long-COVID’: a cross-sectional stu…
C’è sempre una grande, ingombrante e sottovalutata differenza tra il Covid e l’influenza… Long-COVID’: a cross-sectional study of persisting symptoms, biomarker and imaging abnormalities following hospitalisation for COVID-19 | Thorax https://t.co/99cNDwr9
@UnwantedGuest3 Are these the best biomarkers that we have?? How are we going to be able to distinguish long covid from other nonspecific chronic pathology?? https://t.co/QLUgBVp6pp
@ClickingSeason Maybe not all due to neuroticism as some people have measurable biomarkers. https://t.co/ZHAHykfm2H
@alphalioness72 @DeltaNiner187 @SynysterMixer @PolitiFact There have been many studies referring to long-COVID or post-acute sequelae of SARS-CoV-2 infection, including this one dated back to Sept 2020, highlighting persistent symptoms post-discharge: http
@asafpeer @Hopozitzia https://t.co/Uutoh5Rv5H https://t.co/OCATiiZ6fY נזכרתי בעוד אחד שבו התבססו על דיווחים אבל גם עשו בדיקות דם לאחר מכן כדי לבחון כמה פרמטרים. השני הוא מטה אנאליזה להרבה מחקרים בנושא, אז הוא יכול לתת תמונה מעט יותר מאוזנת. אתה מתכוון הברי
@MaximilianLemc1 @RonnySchultz3 @dscharpfMD @concrete_panda_ @KaiSchulze_ 10% bei ambulant behandelten Patienten https://t.co/di7mTe3rBu 10-20% https://t.co/GLJOcTxkTX Über 50% bei Hospitalisierten Patienten https://t.co/k8v2Q02TNd https://t.co/rrBs1NuvPG
@car_trump @ankh_sen_aten @TSlagel999 @Shut_up_squad @denofcinema5 @thatboydave2015 https://t.co/OMqszIF5w2 Another article, another small study.
@hughosmond @jamestwilkinson @SimonPThurston @sajidjavid Long term impairment of lung function and altered blood results https://t.co/aDAnA5cJfF
'Long-COVID': a cross-sectional study of persisting symptoms, biomarker and imaging abnormalities following hospita… https://t.co/SHyPqOD5iD
@KevinGromley @DrTomFrieden From what I read so far, different symptoms for Long-CoViD are more prevalent in patients who required hospitalization. Other symptoms seem to be dependent on other risk factors. For example: https://t.co/3pPBRTGxiQ
RT @silversynergy: @VAware1986 and these were only cases discharged from the hospital, lots of people with mild cases are reporting permane…
RT @silversynergy: @VAware1986 and these were only cases discharged from the hospital, lots of people with mild cases are reporting permane…
@BatistutasH @AlexPattyy https://t.co/27DneAEzUc https://t.co/NzuCaS5mxP https://t.co/TjWGqymR5M If you search https://t.co/CUIbGDQtbm many, many peer reviewed articles will populate.
@vp86eagle @stacey_large https://t.co/27DneAEzUc https://t.co/NzuCaS5mxP https://t.co/TjWGqymR5M If you search https://t.co/CUIbGDQtbm many, many peer reviewed articles will populate. In asymptomatic infection the number can be as low as 30%, but in hospi
@Ander_Mander @leewalkeruk @rrhhyyss1 @LOLOLWTF1 https://t.co/9VdSz0HhHi https://t.co/Af1wzV7mdN https://t.co/a7zcLulcrm I said you shouldn't include the "total number of Canadians", not the "total number of Canadians infected", though you only really nee
One more: ‘Long-COVID’: a cross-sectional study of persisting symptoms, biomarker and imaging abnormalities following hospitalisation for COVID-19 https://t.co/ErIykMPmAo 7/n
RT @leoschilbach: ‚Long-COVID’: a cross-sectional study of persisting symptoms, biomarker and imaging abnormalities following hospitalisati…
‚Long-COVID’: a cross-sectional study of persisting symptoms, biomarker and imaging abnormalities following hospitalisation for COVID-19 https://t.co/f2LljrzyDp
@davymc82 @IrishTimes That is an opinion article; actual scientific studies say otherwise. https://t.co/hrsNEPGdEj
@totoroinatree "30.1% and 9.5% had persistently elevated d-dimer and C reactive protein" https://t.co/5kORin4Aqy
384 survivors after hospitalization... 'Long-COVID': a cross-sectional study of persisting symptoms, biomarker and imaging abnormalities following hospita… https://t.co/SHyPqOD5iD
RT @akinlaborn: ‘Long-COVID’: a cross-sectional study of persisting symptoms, biomarker and imaging abnormalities following hospitalisation…
https://t.co/ggT7S5NSJV 3. From the ARC group: A significant proportion of patients with 'Long COVID' had fatigue, breathlessness, cough and depression, but found follow up useful. This needs to be addressed in an MDT fashion!
RT @MeyadAlkarni: @maudi_ahmed @FatmaMag Check this paper reporting on people admitted to the hospitals and lots had ongoing symptoms for s…
@maudi_ahmed @FatmaMag Check this paper reporting on people admitted to the hospitals and lots had ongoing symptoms for several weeks however these do settle in almost everyone. https://t.co/tHhZ9rTDoR
@effectrode @Mikehun63452579 @JustSom96307716 @itvnews https://t.co/pONO3oWGbs Here you go. Have a read and familiarise yourself with long covid. There's a lot of research behind long-covid.
@effectrode @Mikehun63452579 @JustSom96307716 @itvnews https://t.co/pONO3oF4MS Oh really? So what's this?
@jmcourtright @_Uncle_Monty @HagleyTom1234 @guardian Here's some pro science https://t.co/1o06FbYasJ 53% persistent breathlessness
Här lite tidigare liknande uppföljning relaterad till det som ofta benämns #longcovid: 10/n -> https://t.co/AKumb3bdhI
@BarryCPearson @ShaliniVarma11 @RobertKennedyJr @tensc9 https://t.co/3ijZF8T5ZA median is 54 days post discharge
‘Long-COVID’: a cross-sectional study of persisting symptoms, biomarker and imaging abnormalities following hospitalisation for COVID-19 | Thorax https://t.co/tiFzqQwHOc
@sanity_within @DesignsRosaron @RoseRos24239116 @KatyJayne101 We are doing long covid clinics and find persistent or deteriorating CXR changes in a significant minority. https://t.co/7Pj67spG7K
@christo_comte Par exemple celle-ci, c'est assez récent ? https://t.co/3exbU4MWLQ
@Lewy_B_2013 @Jessica06940275 @GwynneMP @tobyperkinsmp Here is one from London: https://t.co/PaUPy4h4qJ
@shea_cheyennee @smora75 @darakass They don't. It's 35% of severe hospitalized cases. You being a baby isn't a disability. Sorry...... Not that I even believe you given clearly you will say or do anything for your politics. https://t.co/ZR3vitQIhK
@mamasaurusMeg @snorman1776 @wait2moreweeks @MonicaGandhi9 Mount Sinai Hospital in New York has clinic Dr. Dayna McCarthy is a rehab specialist at the center which has treated a thousand patients since it opened its doors in May Articles https://t.co/i6Q2
RT @COPDdoc: @Dr2NisreenAlwan @ONS @ThoraxBMJ These three are UK post-hospitalised #COVID19 follow up studies. https://t.co/Aocme2GwNj htt…
@Dr2NisreenAlwan @ONS @ThoraxBMJ These three are UK post-hospitalised #COVID19 follow up studies. https://t.co/Aocme2GwNj https://t.co/WRktMZkTW9 https://t.co/BUMGOrScMH
‘Long-COVID’: a cross-sectional study of persisting symptoms, biomarker and imaging abnormalities following hospitalisation for COVID-19 https://t.co/bQ2VIcKvrm
@AmicaLuca @vinoveritas_in @Lilalaunefrosc1 @NiemaMovassat https://t.co/yC5RTOHwF8 Und es gibt auch noch weitere.
@andythechemist1 Die rel. Einheit sind Disease-Adjusted Life Years (DALYs), d.H. verloren d. Tot bzw. eingeschränkt d. Langzeitfolgen. Deren Dauer kennen wir noch nicht, aber erste Ergebnisse sind erschreckend, viele sind Wochen nach Verlassen der Klinik
RT @tipssovetorax: "Long-COVID": un estudio transversal de síntomas persistentes, biomarcadores y anomalías en las imágenes después de la h…
"long-COVID2" En 384 pacientes (edad media 59,9 años; 62% varones) con una media de 54 días tras el alta, el 53% tuvo disnea persistente, 34% tos y 69% fatiga. 14,6% tenía depresión/2 https://t.co/3CDhndf0V9
"Long-COVID": un estudio transversal de síntomas persistentes, biomarcadores y anomalías en las imágenes después de la hospitalización por #COVID19/1 https://t.co/3CDhndf0V9